PHARMACOLOGIC THERAPY OF DYSTROPHY IN MAN AND ANIMALS *
- 1 February 1979
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 317 (1) , 400-408
- https://doi.org/10.1111/j.1749-6632.1979.tb56554.x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Avian Muscular Dystrophy: Functional and Biochemical Improvement with DiphenylhydantoinScience, 1977
- Investigation of cranial and other nerves in the mouse with muscular dystrophy.Journal of Neurology, Neurosurgery & Psychiatry, 1975
- PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHYThe Lancet, 1975
- Proximal Myopathy induced by 5-HT-Imipramine simulates Duchenne DystrophyNature, 1974
- Part I Hereditary Primary Myopathies in Laboratory Animals: HEREDITARY MOUSE MUSCULAR DYSTROPHY WITH PARTICULAR EMPHASIS ON PATHOGENESIS AND ATTEMPTS AT THERAPY*Annals of the New York Academy of Sciences, 1966
- Response of genetically dystrophic mice to therapy with hexahydrocoenzyme Q4Biochemical and Biophysical Research Communications, 1966
- Clinical Evaluation of an Oral Anabolic Steroid (Methandrostenolone, Dianabol CIBA) in Children with Muscular Weakness and WastingActa Paediatrica, 1964
- A trial of therapy by nucleosides and nucleotides in muscular dystrophyJournal of Neurology, Neurosurgery & Psychiatry, 1963
- ON THE CLASSIFICATION, NATURAL HISTORY AND TREATMENT OF THE MYOPATHIESBrain, 1954
- Dystrophia muscularis progressivaZeitschrift für Neurologie, 1891